Lana Kandalaft

faculty photo
Adjunct Assistant Professor of Obstetrics and Gynecology
Department: Obstetrics and Gynecology

Contact information
Privat-Docent, Centre de Thérapies Expérimentales
Département d'oncologie
Université de Lausanne
Lausanne, 19104-6160
Office: 215-573-4782
Fax: 215-573-5129
Education:
GSCE (General Certificate of Secondary Education)
London Examination (honors), 1995.
PharmD
University of Jordan School of Pharmacy, Amman Jordan (cum laude), 2000.
PhD (Pharmaceutical Cell Biology and Drug Delivery)
Welsh School of Pharmacy, Cardiff University, UK, 2003.
MTR (Master of Science in Translational Research)
University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 2012.
Permanent link
 

Description of Itmat Expertise

Immunotherapy and ovarian cancer

Selected Publications

Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, Fan L, Kandalaft LE, Tanyi JL, Li C, Yuan CX, Zhang D, Yuan H, Hua K, Lu Y, Katsaros D, Huang Q, Montone K, Fan Y, Coukos G, Boyd J, Sood AK, Rebbeck T, Mills GB, Dang CV, Zhang L: Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell 28(4):529-40, Oct 2015.

Tanyi J, Kandalaft LE, Ophir E, Bobisse, Genolet, R, Zsiros E, Torigian D, Mick, R, Harrari A, Coukos G: Autologous oxidized whole-tumor antigen vaccine in combination with angiogenesis blockade elicits antitumor immune response in ovarian cancer, ASCO, Jun 2015.

Zsiros EZ, Duttagupta P, Dangaj D, Li H, Frank R, Garrabrant T, Hagemann IS, Levine B, June CH, Zhang L, Wang E, Marincola FM, Bedognetti D, Powell DJ Jr, Feldman M, Tanyi JL, Kandalaft LE, Coukos G: The Ovarian Cancer Chemokine Landscape is Conducive to Homing of Vaccine-promed and CD3/CD28 Costimulated T cells Prepared for Adoptive Therapy. Clin Cancer Res 21(12):2840-50, Jun 2015.

Ophir E, Bobisse, S, Kandalaft LE, Tanyi J, Genolet, R, Zsiros E, Torigian D, Mick, R, Harrari A, Coukos G: Increased anti-tumor immunity that correlates with clinical benefit and induction of neoantigens reactivity following autologous tumor lysate-pulsed dendritic cells vaccination in recurrent ovarian cancer, CIMT, May 2015.

Chiang C, Coukos G, Kandalaft LE: Whole Tumor Vaccines-Where are we? Vaccines 3(2), 344-372, Apr 2015.

Chiang C, Balint K, Coukos G, Kandalaft LE: Potential approaches for more successful dendritic cellbased immunotherapy. Expert Opin Biol Ther 2:1-14, Jan 2015.

Chiang C, Balint K, Coukos G, Kandalaft LE: Potential approaches for more successful dendritic cell based immunotherapy. Expert Opin Biol Ther 15(4):569-82, Jan 2015.

Ophir E, Bobisse S, Coukos G, Harari A, Kandalaft LE: Personalized approaches to active immunotherapy in cancer. Biochim Biophys Acta 1865(1):72-82, Jan 2015.

Zsiros E, Tanyi J, Balint K, Kandalaft LE: Immunotherapy for ovarian cancer: recent advances and perspectives. Curr Opin Oncol 26(5):492-500, Sep 2014.

Tanyi J, Kandalaft LE, Zsiros Z, Mantia-Smaldone G, Coukos G: Combinatorial immunotherapy enhances survival in patients with recurrent ovarian cancer-SGO. Mar 2014.

back to top
Last updated: 03/10/2016
The Trustees of the University of Pennsylvania